SHINEWAY PHARM 02877Hong Kong Stock Exchange

7.4251.16%( +0.085 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
SHINEWAY PHARM (02877) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2004-12-02
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG2110P1000
Southbound Connect
Shanghai · Shenzhen

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)3.68B31/112
Net Profit (Last FY)1.11B20/125
ROE (Last FY)11.78%22/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
LI Zhenjiang Executive Director
XIN Yunxia Executive Director
LI Huimin Executive Director
ZHOU Wencheng Non-Executive Director
LIU Shun Fai Independent Non-Executive Director
YEW Yat On Independent Non-Executive Director
WANG Guihua Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-06-10.

About this page

This page shows SHINEWAY PHARM (02877) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.